QTRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
QTRX is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 ready to deploy. The stock is trading weakly in pre-market at $2.99, below the recent $3.05 reference price and near short-term resistance, while the broader trend remains technically bearish. There is no strong proprietary buy signal today, no recent news catalyst, and Wall Street sentiment has turned cautious with lowered price targets. If the investor is unwilling to wait, this is still not an attractive immediate entry.
The short-term momentum is mixed to weak. MACD is positive and expanding, which suggests some near-term upside momentum, but the overall moving average structure is bearish with SMA_200 > SMA_20 > SMA_5. RSI_6 at 73.143 is elevated, indicating the stock is extended rather than clearly undervalued. Price is trading near resistance at R1 2.972 and below R2 3.131, with pivot support at 2.714. Given the bearish longer trend and pre-market decline of 1.97%, the technical setup does not support an immediate long-term buy.
["MACD histogram is above zero and expanding, indicating improving near-term momentum.", "Options flow is call-heavy, suggesting traders are leaning bullish in the short term.", "No recent negative news was reported in the last week.", "Analysts noted the 2026 guide was reiterated, which provides some operational stability."]
["Pre-market price is down 1.97%, showing weak immediate sentiment.", "No news catalysts in the recent week to drive upside.", "TD Cowen and Canaccord both cut price targets to $4 and maintained Hold ratings.", "2Q guidance was described as about 5%+ below consensus, with the year more back-half weighted.", "Technically bearish moving averages remain in place.", "Historical pattern data suggests downside over the next month, with a projected -16.13% move.", "No significant hedge fund, insider, or congress buying activity was identified."]
No usable quarterly financial snapshot was provided due to a data error, so latest-quarter revenue or earnings growth cannot be verified from the dataset. The only financial guidance detail available is that management reiterated 2026 guidance, while 2Q guidance was below consensus and the company appears more weighted to the second half of the year.
Analyst sentiment is cautious. TD Cowen lowered the price target to $4 from $7 and kept a Hold rating on 2026-05-07, citing an in-line 1Q and reiterated 2026 guide but softer 2Q expectations. Canaccord also cut its target to $4 from $8 and maintained Hold on 2026-04-20. Overall, Wall Street pros appear neutral-to-bearish: the positive side is that guidance was reaffirmed, but the negative side is lower targets, no buy ratings in the provided data, and weaker near-term expectations.
